HD-OPM Archive
Topics › Statins

Statin use linked to 35% lower odds of liver cancer in UK database study

Louis Nervegna · Sep 15, 2026 · ♥ 10 reactions · 0 comments · original Facebook post
StatinsCancerPCSK9, ezetimibe & newer drugs
AI summary & key facts

A UK Clinical Practice Research Datalink case-control study of 3,719 liver cancer cases and 14,876 controls found statin users had 35% lower odds of liver cancer, and cholesterol absorption inhibitors (ezetimibe class) 31% lower odds. This is an association, not proof, and non-statin findings need replication.

Link to full journal paper:

Paper · Cancer · 2024Use of cholesterol-lowering medications in relation to risk of primary liver cancer in the Clinical Practice Research Datalink.Conclusion: Cholesterol absorption inhibitors may be associated with reduced liver cancer risk. Whether bile acid sequestrant use was associated with increased risk was only partially supported in the current study.pmc.ncbi.nlm.nih.gov

#statinsHD #statinsliverHD #statinscancerHD #livercancerHD #liverHD #cancerHD #ezetimibeHD #ezetimbeliverHD #ezetimibecancerHD #bileacidsequestrantsHD

Research cited

Shared from Vita Pulse · original post

A large UK study found that people taking statins had 35% lower odds of liver cancer compared with those who were not using these medications. Researchers analyzed health records from the UK Clinical Practice Research Datalink, comparing 3,719 people diagnosed with liver cancer with 14,876 matched individuals without cancer. The study also examined non-statin cholesterol-lowering drugs and found that cholesterol absorption inhibitors were associated with 31% lower odds of liver cancer. This association remained in analyses that accounted for factors such as type 2 diabetes and chronic liver disease.

Published in Cancer in 2024, the study adds to research investigating whether cholesterol-lowering medications may have effects beyond cardiovascular health. However, the findings show an association, not proof that statins or cholesterol absorption inhibitors prevent liver cancer. People should not start or change these medications specifically for cancer prevention based on this study. Researchers noted that the findings, particularly those involving non-statin medications, need to be replicated in other populations and studied further before these drugs could be considered for liver cancer prevention.

#LiverCancer #Statins #CancerResearch #LiverHealth #MedicalResearch

May be an image of text that says 'STATIN Fablers STATIN 40 mg 30 STATIN USE ASSOCIATED WITH LOWER LIVER CANCER RISK IN UK STUDY @vitapulse'
← newer: High-dose omega-3 raises AFib risk in high-CVD-risk people, older: Magnesium chloride 248 mg/day improved mild-to-moderate depr →